KR920012073A - 크로만 유도체 - Google Patents

크로만 유도체 Download PDF

Info

Publication number
KR920012073A
KR920012073A KR1019910021972A KR910021972A KR920012073A KR 920012073 A KR920012073 A KR 920012073A KR 1019910021972 A KR1019910021972 A KR 1019910021972A KR 910021972 A KR910021972 A KR 910021972A KR 920012073 A KR920012073 A KR 920012073A
Authority
KR
South Korea
Prior art keywords
formula
cnh
pyridazinyl
cyano
nso
Prior art date
Application number
KR1019910021972A
Other languages
English (en)
Other versions
KR100220002B1 (ko
Inventor
게릭케 롤프
프레드 바움가르쓰 만
루이스 인게보르그
하르팅 위르겐
베르그만 롤프
Original Assignee
호이만, 쉬틀러
메르크 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호이만, 쉬틀러, 메르크 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁 filed Critical 호이만, 쉬틀러
Publication of KR920012073A publication Critical patent/KR920012073A/ko
Application granted granted Critical
Publication of KR100220002B1 publication Critical patent/KR100220002B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

크로만 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 일반식(I)의 크로만 유도체 및 이의 염.
    상기식에서 R1은 A이고, R2, R8및 R9은 각각 H 또는 A이고, R1및 R2는 함께 탄소수 3 내지 6의 알킬렌이고, R3는 H, OH, OA 또는 OR10이고, R4는 H이고, R3및 R4는 함께 결합을 갖고, R5는 피리딜, 피리다지닐, 피리미디닐, 피라지닐, 옥소디히드로피리딜, 옥소디히드로피리다지닐, 오소디히드로피리미디닐 또는 옥소디히드로피라지닐의 라디칼로, 이 라디칼은 A, F, CL, Br, I, OH, OA, OR10, SH, NO2, NH2, R10NH, HOOC 및/또는 AOOC로 치환되지 않았거나, 단치환 또는 이치환된 라디칼이고, R6및 R7은 각각 H, A, HO, AO, CHO, ACO, ACS, HOOC, AOOC, AO-CS, ACOO, A-CS-O, HO-CnH2n, HS-CnH2n, NO2, NH2, NHA, NA2, CN, F, Cl, Br, I, CF3, ASO, ASO2, AO-SO2, R10NH, AO-CO-NH, H2NSO, HANSO, A2NSO, H2NSO2, HANSO2, A2NSO2, N2NCO, HANCO, A2NCO, H2NCS, HANCS, A2NCS, ASONH, ASO2NH, AOSONH, AOSO2NH, ACO-CnH2n, 니트로-CnH2n, 시아노-CnH2n, A-C(=NOH) 또는 A-C(=NNH2)이고, A는 탄소수 1 내지 6의 알킬이고, R10은 탄소수 1 내지 8의 알칸오일 또는 탄소수 7내지 11의 아로일이고, n은 1내지 6의 수이다.
  2. a) 2, 2-디메틸-4-(1-메틸-1, 6-디히드로-6-옥소-3-피리다지닐-아미노)-6-시아노-3-크로만을, b) 트란스-3, 4-디히드로-4-(1, 6-디히드로-1-메틸-6-옥소-3-피리다지닐-아미노)-2,2,3-트리메틸-6-시아노-3-크로만올, c) (4R, 3R)-2,2-디메틸-4-(1-메틸-1, 6-디히드로-6-옥소-3-피리다지닐-아미노-6-시아노-3-크로만올, d) 2, 2-디메틸-4-〔N-(1-메틸-6-옥소-3-피리다지닐)-1-메틸아미노〕-6-시아노-3-크로만올.
  3. 일반식(II)의 크로만올
    (상기식에서, X-Y는또는 -CHE-CR3R8이며, E는 C1, Br, I 또는 반응적으로 에스테르화 할 수 있는 OH 그룹이고, R1, R2, R3, R6, R7및 R8은 일반식(I)에서 정의한 바와 같다.) 일반식(III)의 화합물과
    R5-NH-R9(III)
    (상기식에서, R5, R9은 일반식(I)에서 정의한 바와 같다) 또는 이의 반응성 유도체중 하나와 반응시키고/시키거나, R3가 OH이고 R4는 H인 일반식(I)의 화합물은 탈수하고/하거나, 일반식(I)의 화합물에서, 라디칼 R3, R5, R6및 R7중의 하나 또는 그이상을 다른 라디칼 R3, R5, R6, R7로 전환시키고/시키거나 일반식(I)의 염기성 화합물을 산으로 처리하여 산부가 염중 하나로 전환시키는 것을 특징으로 하는 제1항에 따른 일반식(I)의 크로만 유도체를 제조하는 방법.
  4. 일반식(I)의 화합물 및/또는 이의 생리학적으로 허용가능한 염중 하나를 적어도 하나의 고형, 액형 또는 반고형 부형제 또는 보조제와 함께 투여에 적합한 형태로 전환시키는 것을 특징으로 하는 약학적 제제의 제조방법.
  5. 일반식(I)의 적어도 하나의 화합물 및/또는 이의 생리학적으로 허용가능한 염중 하나를 함유하는 약학적 제제.
  6. 질병 치료용의 일반식(I)의 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910021972A 1990-12-05 1991-12-02 크로만 유도체 KR100220002B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4038752A DE4038752A1 (de) 1990-12-05 1990-12-05 Chromanderivate
DEP4038752.6 1990-12-05

Publications (2)

Publication Number Publication Date
KR920012073A true KR920012073A (ko) 1992-07-25
KR100220002B1 KR100220002B1 (ko) 1999-09-01

Family

ID=6419627

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910021972A KR100220002B1 (ko) 1990-12-05 1991-12-02 크로만 유도체

Country Status (18)

Country Link
US (1) US5238937A (ko)
EP (1) EP0489327B1 (ko)
JP (1) JPH04300880A (ko)
KR (1) KR100220002B1 (ko)
AT (1) ATE166649T1 (ko)
AU (1) AU645373B2 (ko)
CA (1) CA2056845A1 (ko)
CZ (1) CZ280911B6 (ko)
DE (2) DE4038752A1 (ko)
DK (1) DK0489327T3 (ko)
ES (1) ES2119751T3 (ko)
GR (1) GR3027561T3 (ko)
HU (1) HU215518B (ko)
IE (1) IE914213A1 (ko)
PT (1) PT99688B (ko)
SK (1) SK279095B6 (ko)
TW (1) TW209863B (ko)
ZA (1) ZA919573B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
CA2153498A1 (en) 1993-11-10 1995-05-18 Hidetsura Cho Chroman derivative and medicinal use thereof
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
KR20070003349A (ko) * 2005-07-01 2007-01-05 한 성 육 가설 철도교용 체결장치
WO2007027780A2 (en) * 2005-09-01 2007-03-08 Janssen Pharmaceutica N.V. Benzopyran and pyranopyridine derivatives as potassium channel openers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
CH674984A5 (ko) * 1987-05-16 1990-08-15 Sandoz Ag
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Also Published As

Publication number Publication date
HU215518B (hu) 1999-01-28
DK0489327T3 (da) 1999-03-22
DE59108997D1 (de) 1998-07-02
AU645373B2 (en) 1994-01-13
JPH04300880A (ja) 1992-10-23
CS367491A3 (en) 1992-06-17
DE4038752A1 (de) 1992-06-11
PT99688A (pt) 1992-10-30
HU913797D0 (en) 1992-02-28
HUT62000A (en) 1993-03-29
AU8831391A (en) 1992-06-11
ES2119751T3 (es) 1998-10-16
GR3027561T3 (en) 1998-11-30
PT99688B (pt) 1999-05-31
EP0489327A1 (de) 1992-06-10
US5238937A (en) 1993-08-24
CA2056845A1 (en) 1992-06-06
IE914213A1 (en) 1992-06-17
TW209863B (ko) 1993-07-21
EP0489327B1 (de) 1998-05-27
ZA919573B (en) 1992-08-26
CZ280911B6 (cs) 1996-05-15
ATE166649T1 (de) 1998-06-15
KR100220002B1 (ko) 1999-09-01
SK279095B6 (sk) 1998-06-03

Similar Documents

Publication Publication Date Title
KR880007507A (ko) 크로만 유도체
RU2325381C2 (ru) Замещенные гетероциклические производные и их применение
PT79834B (fr) Procede de preparation de nouveaux derives de la xanthine
DE68920125T2 (de) Pyrimidindion-Derivate, Verfahren zu deren Herstellung und diese enthaltende antiarrythmische Mittel.
KR890002060A (ko) 옥사졸리디논 화합물
KR920012073A (ko) 크로만 유도체
KR910000711A (ko) 크로만 유도체
OA07508A (fr) Nouveaux dérivés de la xantine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
KR910000713A (ko) 크로만 유도체
KR910004602A (ko) 크로만 유도체
KR910011812A (ko) 염증성 장 질환 치료용 화합물
KR900006326A (ko) 크로만 유도체
PT69618A (de) Neue imidazolderivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praparate
KR910002845A (ko) 크로만 유도체
KR910002842A (ko) 크로만 유도체
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
KR940003953A (ko) 1. 4-벤조디옥산 유도체
OA07926A (fr) Nouveaux dérivés de la quinoléine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
KR910020004A (ko) 이소크로만 유도체
ES543804A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dialquilaminoalcoxi sustituido y de sus sa-les de adicion acidas y amonicas cuaternarias
OA07308A (fr) Nouveaux dérivés de benzodioxine, leurs procédés de préparation et les compositions pharmaceutiques les renfermant .
KR910021400A (ko) 옥사졸리디논
KR890005113A (ko) 아자크로만 유도체
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
EP0207287A3 (de) Indolinderivate, Verfahren zu ihrer Herstellung und diese Indolinderivate enthaltende kosmetische Lichtschutzmittel

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee